Gene · 407036
Papers1,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma. | Noncoding RNA Res | 2024 | 38075204 | PubTator, text mining | PubMed |
| High glucose promotes macrophage M1 polarization through miR-32/Mef2d/cAMP signaling pathway. | Genes Dis | 2024 | 37692480 | PubTator, text mining | PubMed |
| OTUD3 suppresses the mTORC1 signaling by deubiquitinating KPTN. | Front Pharmacol | 2023 | 38288086 | PubTator, text mining | PubMed |
| Uncovering transcriptomic biomarkers for enhanced diagnosis of methamphetamine use disorder: a comprehensive review. | Front Psychiatry | 2023 | 38260797 | PubTator, text mining | PubMed |
| Unraveling the regulatory network of miRNA expression in Potato Y virus-infected of Nicotiana benthamiana using integrated small RNA and transcriptome sequencing. | Front Genet | 2023 | 38259624 | PubTator, text mining | PubMed |
| Gene crosstalk between COVID-19 and preeclampsia revealed by blood transcriptome analysis. | Front Immunol | 2023 | 38259479 | PubTator, text mining | PubMed |
| Advances in Diagnostic Tools and Therapeutic Approaches for Gliomas: A Comprehensive Review. | Sensors (Basel) | 2023 | 38139688 | PubTator, text mining | PubMed |
| FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies. | Front Pharmacol | 2023 | 38027013 | PubTator, text mining | PubMed |
| miRNA Expression Patterns in Early- and Late-Stage Prostate Cancer Patients: High-Throughput Analysis. | Biomedicines | 2023 | 38002073 | PubTator, text mining | PubMed |
| Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy. | Acta Pharm Sin B | 2023 | 37969742 | PubTator, text mining | PubMed |
| Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges. | Genes (Basel) | 2023 | 37895255 | PubTator, text mining | PubMed |
| MicroRNAs in Prostate Cancer: Implications for Treatment Response and Therapeutic Targets. | Cancers (Basel) | 2023 | 37894390 | PubTator, text mining | PubMed |
| A MEC-2/stomatin condensate liquid-to-solid phase transition controls neuronal mechanotransduction during touch sensing. | Nat Cell Biol | 2023 | 37857834 | PubTator, text mining | PubMed |
| Vascular calcification: from the perspective of crosstalk. | Mol Biomed | 2023 | 37851172 | PubTator, text mining | PubMed |
| Deubiquitinase OTUD3: a double-edged sword in immunity and disease. | Front Cell Dev Biol | 2023 | 37829187 | PubTator, text mining | PubMed |
| Identification of the potential regulatory interactions in rheumatoid arthritis through a comprehensive analysis of lncRNA-related ceRNA networks. | BMC Musculoskelet Disord | 2023 | 37814309 | PubTator, text mining | PubMed |
| Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications. | Front Immunol | 2023 | 37767098 | PubTator, text mining | PubMed |
| Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer. | Int J Mol Sci | 2023 | 37761978 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs in Colorectal Cancer: Navigating the Intersections of Immunity, Intercellular Communication, and Therapeutic Potential. | Biomedicines | 2023 | 37760852 | PubTator, text mining | PubMed |
| Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases. | Biology (Basel) | 2023 | 37759656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407036/papers?page=2